


With expansion in the generics market and fewer FDA drug approvals, growth in dollar sales for drugs was down in 2007, though the number of prescriptions dispensed increased slightly.

The FDA directs that all SSRIs contain a black box warning. Patients taking these medications may continue therapy, but they should be monitored carefully on a regular basis.

As summer approaches, it is important to be aware of the harm excessive sun exposure can cause. Pharmacists are in a unique position to increase patient awareness of potential risk factors and assist them in the proper selection and application of sunscreen products.
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADA 2026: Semaglutide Add-On Reduces Glycemic Burden, Cardiometabolic Risk in Older Adults With T2D
2
ADA 2026: Earlier GLP-1 and SGLT-2 Use Recommended From Diabetes Diagnosis, Expert Says
3
ADA 2026: Why Some T2D Patients Don't Respond to GLP-1 RAs—And What Pharmacists Should Screen For
4
New Research Suggests Bempedoic Acid Outperforms Ezetimibe for Heart Health in Patients with Type 2 Diabetes
5